Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Older Antipsychotics May Be Better Option for Troubled Kids
WSJ Online
Monday, September 15, 2008 - 10:37am
tags:
Carl Icahn increases ownership stake in Amylin Pharmaceuticals to 7.3 percent
Yahoo/AP
Monday, September 15, 2008 - 8:53am
tags:
Antigenics to Present on Unique Cancer Therapy
Cafepharma Detailpiece
Monday, September 15, 2008 - 8:51am
tags:
Ownership of Erbitux Follow-On Is Central to ImClone Takeover
Seeking Alpha
Sunday, September 14, 2008 - 12:28pm
tags:
Bristol-Meyers Squibb vs. Imclone: Icahn Stirs Up the Pot
Seeking Alpha
Sunday, September 14, 2008 - 12:26pm
tags:
CV Therapeutics to get up to $315M for Ranexa licensing
Washington Business Journal, DC
Sunday, September 14, 2008 - 12:25pm
tags:
Expiring Patents Ignite Biotech Boom
Seeking Alpha
Sunday, September 14, 2008 - 12:23pm
tags:
Sun Pharmaceuticals gets USFDA nods for Alendronate Sodium tablets
Stock Watch, India
Sunday, September 14, 2008 - 12:22pm
tags:
Biopharma business sets up one-stop-shop online
Sunday Business Post, Ireland
Sunday, September 14, 2008 - 12:20pm
tags:
Go East, young biomed company
Globes, Israel
Sunday, September 14, 2008 - 12:08pm
tags:
Bayer CEO says not vulnerable to takeover-paper
Forbes
Sunday, September 14, 2008 - 12:06pm
tags:
China Biopharma Week in Review: Broad Views, Individual Companies
Seeking Alpha
Sunday, September 14, 2008 - 12:05pm
tags:
Teva Says U.S. Court Denies It Risperdal Exclusivity
Bloomberg
Sunday, September 14, 2008 - 12:04pm
tags:
Spine tingler: Is Medtronic money swaying surgeons? 8 Minnesota doctors among those named in federal lawsuit
Pioneer Press, MN
Sunday, September 14, 2008 - 12:04pm
tags:
RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors
Yahoo
Saturday, September 13, 2008 - 12:47pm
tags:
Development Focus Pays Off For Biotech
Yahoo/Investor's Business Daily
Saturday, September 13, 2008 - 12:46pm
tags:
Fitch affirms 'A+' ratings for Bristol-Myers
Forbes
Saturday, September 13, 2008 - 12:45pm
tags:
Cerimon reports positive results from Phase II study of topical pain patch
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:43pm
tags:
Cyclacel expands Phase II sapacitabine trial to include MDS patients
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:42pm
tags:
Calando Pharmaceuticals initiates Phase II ovarian cancer study
Pharmaceutical Business Review
Saturday, September 13, 2008 - 12:41pm
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.